With its unique mechanism of action, semaglutide offers the potential for significant and sustained fat loss, improved cardiometabolic health, and a reduced risk of type 2 diabetes
Retrieved from Fuchs FD, & Whelton PK
Each phase includes appetite assessment, weight tracking, and metabolic monitoring to inform safe progression
Starting at 1 mg significantly increases nausea, vomiting, and gastrointestinal side effects, often leading to treatment discontinuation
People who have difficulty processing vitamin B12 may develop anemia
The PNPLA3 I148M variant, which is highly prevalent in Latin American populations, has been strongly associated with increased risk of MASLD, progression of liver disease, and HCC [101]